MMP9 and breast carcinoma: The aim of this study was to validate previously determined mRNA biomarkers of DOX-induced presymptomatic cardiotoxicity, PGLYRP1, CAMP, MMP9, and CEACAM8 and to assay their protein expression in breast cancer patients’ circulation.